SELECT LANGUAGE BELOW

Woman claims 23andMe results confirm she is the daughter of sculptor Fred Eversley

Woman claims 23andMe results confirm she is the daughter of sculptor Fred Eversley

A woman from California, Kelly Krechmer, claims her genetic test from last year supports what her mother, Patricia, told her throughout her life about her parentage. At 54, Krechmer is aiming for a share of artist Fred Eversley’s substantial $39 million estate, as indicated in documents submitted to a Manhattan court. She asserts that she […]

Americans Are Quickly Removing Their DNA Profiles from 23andMe

Americans Are Quickly Removing Their DNA Profiles from 23andMe

Data Removal Requests from 23andMe Customers Surge Around 2 million customers of 23andMe, making up about 15% of its client base, are asking genetic testing firms to erase their data. This comes in response to the company’s recent bankruptcy filing and its proposed sale to Regeneron. The Breibart News has shared guidance on how users […]

Cornyn, Grassley, and Klobuchar introduce legislation to safeguard data during 23andMe bankruptcy

New Bipartisan Measures Aim to Safeguard Genetic Data Republican Senators John Cornyn and Chuck Grassley, along with Democrat Senator Amy Klobuchar, are pushing for new bipartisan legislation to protect sensitive genetic information. Their initiative responds to increasing privacy concerns, particularly following the bankruptcy of 23andMe, as reported recently. The senators have introduced the DONT SELL […]

23andMe, once a favorite in Silicon Valley, bought by Regeneron Pharmaceuticals

Regeneron Pharmaceuticals to Acquire 23AndMe for $256 Million Regeneron Pharmaceuticals has announced its intent to purchase the bankrupt genetic testing company 23AndMe for $256 million. This move presents a chance for Regeneron to obtain a wealth of genetic samples and data, including details from over 15 million customers. However, this acquisition has sparked concerns among […]

Regeneron Pharmaceuticals is set to purchase 23andMe and its genetic information for $256 million.

Regeneron Pharmaceuticals to Acquire 23andMe from Bankruptcy Regeneron Pharmaceuticals announced on Monday its intention to purchase 23andMe for $256 million as the company emerges from bankruptcy. This acquisition includes 23andMe’s personal genomic service, Total Health and Research Services, along with a substantial biobank that holds genetic data from over 15 million customers. All genetic testing […]

Cold cases could be cracked in potential sale of 23andMe, expert says

Join Fox News to access this content You have reached your maximum number of articles. Log in or create a free account to continue reading. By entering your email to continue, you agree to Fox News Terms of Use and Privacy Policy. This includes notifications of financial incentives. Please enter a valid email address. Are […]